{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:50:48Z","timestamp":1791859848115,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303785\/2020-9"],"award-info":[{"award-number":["303785\/2020-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404446\/2021-3"],"award-info":[{"award-number":["404446\/2021-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E\u221226\/010.002136\/2019"],"award-info":[{"award-number":["E\u221226\/010.002136\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E\u221226\/200.984\/2022"],"award-info":[{"award-number":["E\u221226\/200.984\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.mce.2024.112177","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T16:21:59Z","timestamp":1708186919000},"page":"112177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice"],"prefix":"10.1016","volume":"585","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-3201","authenticated-orcid":false,"given":"Isabela Macedo Lopes","family":"Vasques-Monteiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Fernandes-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolline Santos","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Maria","family":"Silva-Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-1386","authenticated-orcid":false,"given":"Julio Beltrame","family":"Daleprane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-9569","authenticated-orcid":false,"given":"Vanessa","family":"Souza-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2024.112177_bib1","doi-asserted-by":"crossref","DOI":"10.3945\/jn.110.135210","article-title":"PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver","volume":"141","author":"Abdelmegeed","year":"2011","journal-title":"J. Nutr."},{"key":"10.1016\/j.mce.2024.112177_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21176402","article-title":"Gut microbiota and intestinal trans-epithelial permeability","volume":"21","author":"Allam-Ndoul","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2024.112177_bib3","doi-asserted-by":"crossref","DOI":"10.1017\/S0007114520000380","article-title":"Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism","volume":"123","author":"Amabebe","year":"2020","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.mce.2024.112177_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in NAFLD - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib5","doi-asserted-by":"crossref","first-page":"155217","DOI":"10.1016\/j.metabol.2022.155217","article-title":"2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"Boutari","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2024.112177_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2010.02.012","article-title":"Fatty liver: role of inflammation and fatty acid nutrition","volume":"82","author":"Byrne","year":"2010","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.mce.2024.112177_bib7","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2024.112177_bib8","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.celrep.2019.10.042","article-title":"Intestinal IL-17R signaling constrains IL-18-driven liver inflammation by the regulation of microbiome-derived products","volume":"29","author":"Castillo-dela Cruz","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mce.2024.112177_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-011-1147-1","article-title":"A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies","volume":"459","author":"Catta-Preta","year":"2011","journal-title":"Virchows Arch. : Int. J. Pathol."},{"key":"10.1016\/j.mce.2024.112177_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mce.2024.112177_bib11","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/j.1476-5381.2010.00671.x","article-title":"Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation","volume":"160","author":"Collino","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mce.2024.112177_bib12","article-title":"Recent stereological methods for cell biology: a brief survey","volume":"258","author":"Cruz-Orive","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mce.2024.112177_bib13","doi-asserted-by":"crossref","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mce.2024.112177_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/0378-1119(94)90060-4","article-title":"Rules and guidelines for nomenclature of mouse genes. International committee on standardized genetic nomenclature for mice","volume":"147","author":"Davisson","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.mce.2024.112177_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110480","article-title":"Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet","volume":"493","author":"de Mendonca","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/807356","article-title":"Modulation of tight junction structure and function by kinases and phosphatases targeting occludin","author":"D\u00f6rfel","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.mce.2024.112177_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(95)92143-5","article-title":"A simple measure of insulin resistance","volume":"346","author":"Duncan","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2024.112177_bib18","first-page":"796","volume":"vol. 75","year":"1980"},{"key":"10.1016\/j.mce.2024.112177_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plefa.2016.10.001","article-title":"Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: relationship to tissue development and aging","volume":"114","author":"Echeverria","year":"2016","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.mce.2024.112177_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jnutbio.2018.09.012","article-title":"Reduction of high-fat diet-induced liver proinflammatory state by eicosapentaenoic acid plus hydroxytyrosol supplementation: involvement of resolvins RvE1\/2 and RvD1\/2","volume":"63","author":"Echeverria","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.mce.2024.112177_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mce.2024.112177_bib22","first-page":"115","article-title":"Saroglitazar, a dual PPAR-\u03b1\/\u03b3 agonist, alleviates LPS-induced hepatic and renal injury in rats","author":"Francis","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.mce.2024.112177_bib23","doi-asserted-by":"crossref","DOI":"10.3164\/jcbn.09-83","article-title":"A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 mice fed a high fat diet","volume":"46","author":"Fraulob","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.mce.2024.112177_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/CS20110373","article-title":"Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet","volume":"123","author":"Fraulob","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.mce.2024.112177_bib25","doi-asserted-by":"crossref","DOI":"10.1369\/jhc.6A6944.2006","article-title":"Differential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse intestine","volume":"54","author":"Fujita","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mce.2024.112177_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1247\/csf.22068","article-title":"Reconstitution of functional tight junctions with individual claudin subtypes in epithelial cells","volume":"48","author":"Furuse","year":"2023","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.mce.2024.112177_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejpb.2022.10.006","article-title":"Lipopolysaccharide structure and the phenomenon of low endotoxin recovery","volume":"180","author":"Gorman","year":"2022","journal-title":"Eur. J. Pharm. Biopharm. : Offic. J. Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik EV"},{"key":"10.1016\/j.mce.2024.112177_bib28","first-page":"21","article-title":"Microbial medicine: prebiotic and probiotic functional foods to target obesity and metabolic syndrome","author":"Green","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2024.112177_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mce.2024.112177_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000256469.06782.d5","article-title":"Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level","volume":"27","author":"Hiuge","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.mce.2024.112177_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-016-0775-y","article-title":"PPAR-\u0391 agonist WY-14643 inhibits LPS-induced inflammation in synovial fibroblasts via NF-kB pathway","volume":"59","author":"Huang","year":"2016","journal-title":"J. Mol. Neurosci. : MN"},{"key":"10.1016\/j.mce.2024.112177_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2024.112177_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene \u2013 a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.mce.2024.112177_bib35","article-title":"The PPAR \u03b1\/\u03b3 agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2024.112177_bib36","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.mce.2024.112177_bib37","doi-asserted-by":"crossref","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.mce.2024.112177_bib38","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","article-title":"Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice","volume":"155","author":"Luo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2024.112177_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.mce.2024.112177_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113164","article-title":"High-fat, western-style diet, systemic inflammation, and gut microbiota: a narrative review","volume":"10","author":"Malesza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mce.2024.112177_bib41","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00124.2013","article-title":"Dipeptidyl peptidase IV inhibitor lowers PPAR\u03b3 agonist-induced body weight gain by affecting food intake, fat mass, and beige\/brown fat but not fluid retention","volume":"306","author":"Masuda","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"key":"10.1016\/j.mce.2024.112177_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12397","article-title":"Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice","volume":"83","author":"Matsushita","year":"2016","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mce.2024.112177_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110791","article-title":"PPAR-alpha activation counters brown adipose tissue whitening: a comparative study between high-fat- and high-fructose-fed mice","volume":"78","author":"Miranda","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.mce.2024.112177_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111839","article-title":"Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity","author":"Miranda","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112253","article-title":"PPARalpha\/gamma synergism activates UCP1-dependent and -independent thermogenesis and improves mitochondrial dynamics in the beige adipocytes of high-fat fed mice","volume":"117","author":"Miranda","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.mce.2024.112177_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(-\/-) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mce.2024.112177_bib47","first-page":"45","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","author":"Park","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mce.2024.112177_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mce.2024.112177_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.domaniend.2011.05.005","article-title":"Trans-10, cis-12 conjugated linoleic acid and the PPAR-\u03b3 agonist rosiglitazone attenuate lipopolysaccharide-induced TNF-\u03b1 production by bovine immune cells","volume":"41","author":"Perdomo","year":"2011","journal-title":"Domest. Anim. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.regpep.2011.11.004","article-title":"The insulin sensitizing effects of PPAR-\u03b3 agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats","volume":"174","author":"Pita","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.mce.2024.112177_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule A promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mce.2024.112177_bib52","doi-asserted-by":"crossref","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mce.2024.112177_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Faseb. J. : Offic. Pub. Federat. Am. Soc. Experim. Biol."},{"key":"10.1016\/j.mce.2024.112177_bib54","doi-asserted-by":"crossref","DOI":"10.1530\/JME-21-0084","article-title":"A PPAR-alpha agonist and DPP-4 inhibitor mitigate adipocyte dysfunction in obese mice","volume":"68","author":"Santana-Oliveira","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JOE-20-0139","article-title":"Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin","volume":"247","author":"Silva-Veiga","year":"2020","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.mce.2024.112177_bib56","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v28.i17.1814","article-title":"Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice","volume":"28","author":"Silva-Veiga","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2024.112177_bib57","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.3748\/wjg.v29.i26.4136","article-title":"Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: focus on the adipose tissue, liver, and pancreas","volume":"29","author":"Souza-Tavares","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mce.2024.112177_bib58","article-title":"Regulation of the intestinal barrier by nutrients: the role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Animal Sci. J. = Nihon chikusan Gakkaiho"},{"key":"10.1016\/j.mce.2024.112177_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.plefa.2015.04.002","article-title":"Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: relation to LCPUFA depletion in liver and extrahepatic tissues","volume":"98","author":"Valenzuela","year":"2015","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.mce.2024.112177_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2017.07.003","article-title":"Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice","volume":"140","author":"Veiga","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.mce.2024.112177_bib61","volume":"vol. 334","author":"Wu","year":"2011"},{"key":"10.1016\/j.mce.2024.112177_bib62","first-page":"1133","article-title":"Impact of a high-fat diet on intestinal stem cells and epithelial barrier function in middle-aged female mice","volume":"21","author":"Xie","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.mce.2024.112177_bib63","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1021\/acs.jproteome.1c00197","article-title":"Integration of FGF21 signaling and metabolomics in high-fat diet-induced obesity","volume":"20","author":"Zhou","year":"2021","journal-title":"J. Proteome Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720724000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720724000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T02:18:21Z","timestamp":1727230701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720724000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":63,"alternative-id":["S0303720724000339"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2024.112177","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2024.112177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112177"}}